NERVGEN PHARMA CORP.

Insiders NervGen Pharma Corp.

Equities

NGEN

CA64082X2032

Market Closed - Toronto S.E. Other stock markets 03:57:02 2024-04-26 pm EDT			5-day change	1st Jan Change
2.11 ^CAD	+4.46%		-5.38%	-21.85%

Apr. 17	NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update	MT
Apr. 17	NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nervgen Pharma Appoints John Ruffolo to Board of Directors	23-10-17	CI
Nervgen Pharma Corp. Appoints Michael Kelly as CEO	23-04-10	CI
NervGen Pharma Appoints Michael Kelly as President & Chief Executive Officer	23-04-10	MT
NervGen Pharma Corp. Announces Executive Changes	22-09-22	CI
NervGen Pharma Corp. Announces Executive Changes	22-09-22	CI
NervGen Pharma Corp. Appoints Adam Rogers to its Board of Directors	22-07-14	CI
NervGen Pharma Corp. Announces Executive Changes	22-04-13	CI
NervGen Pharma Corp. Announces Spinal Cord Injury Clinical Advisory Board	21-10-27	CI
NervGen Pharma Corp. Appoints Krista Mckerracher and Glenn Ives to Its Board of Directors	21-09-10	CI
NervGen Pharma Corp. Establishes Multiple Sclerosis Clinical Advisory Board	21-07-15	CI
NervGen Pharma Corp. Expands Alzheimer's Disease, Scientific Advisory Board	21-07-12	CI
NervGen Pharma Corp. Announces the Appointment of Daniel Mikol as Chief Medical Officer, Effective May 5, 2021	21-04-22	CI
NervGen Pharma Establishes Alzheimer's Disease Scientific Advisory Board	21-01-26	CI
NervGen Pharma Corp. Appoints Dr. Randall Kaye to the Company's Board of Directors	20-10-28	CI
NervGen Pharma Corp. Announces Resignation of Lloyd Mackenzie as Chief Operating Officer, Effective October 2, 2020	20-09-10	CI
NervGen Pharma Corp. Announces Management Changes	19-11-27	CI
NervGen Pharma Corp. Announces Management Changes	19-05-30	CI
NervGen Pharma Corp. Announces Appointment of Amy Franke as Vice President, Clinical Operations	19-04-01	CI
NervGen Pharma Corp. Appoints Michael J. Abrams to the Board of Directors	18-09-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer